Masashi Okada
Yamagata University
H-index: 32
Asia-Japan
Top articles of Masashi Okada
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Givinostat inhibition of sp1-dependent MGMT expression sensitizes glioma stem cells to temozolomide | Anticancer Research | Yurika Nakagawa-Saito Yuta Mitobe Keita Togashi Shuhei Suzuki Asuka Sugai | 2023/3/1 |
Antagonizing MDM2 overexpression induced by MDM4 inhibitor CEP-1347 effectively reactivates wild-type p53 in malignant brain tumor cells | Cancers | Yuta Mitobe Shuhei Suzuki Yurika Nakagawa-Saito Keita Togashi Asuka Sugai | 2023/8/30 |
The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo | Biomedicines | Yuta Mitobe Shuhei Suzuki Yurika Nakagawa-Saito Keita Togashi Asuka Sugai | 2023/7/12 |
Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents | International Journal of Molecular Sciences | Yurika Nakagawa-Saito Yuta Mitobe Shuhei Suzuki Keita Togashi Asuka Sugai | 2023/6/28 |
CEP-1347 targets MDM4 protein expression to activate p53 and inhibit the growth of glioma cells | Anticancer Research | Yuta Mitobe Yurika Nakagawa-Saito Keita Togashi Shuhei Suzuki Asuka Sugai | 2022/10/1 |
Inhibition of the Phospholipase Cε–c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties | International Journal of Molecular Sciences | Masashi Okada Yurika Nakagawa-Saito Yuta Mitobe Asuka Sugai Keita Togashi | 2022/8/7 |
HDAC class I inhibitor domatinostat preferentially targets glioma stem cells over their differentiated progeny | International Journal of Molecular Sciences | Yurika Nakagawa-Saito Shinichi Saitoh Yuta Mitobe Asuka Sugai Keita Togashi | 2022/7/22 |
Gemcitabine cooperates with everolimus to inhibit the growth of and sensitize malignant meningioma cells to apoptosis induced by navitoclax, an inhibitor of anti-apoptotic bcl … | Cancers | Masahiro Yamamoto Shuhei Suzuki Keita Togashi Asuka Sugai Masashi Okada | 2022/3/27 |
Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax | Neuro-Oncology Advances | Masahiro Yamamoto Tomomi Sanomachi Shuhei Suzuki Keita Togashi Asuka Sugai | 2021/1/1 |
Targeting folate metabolism is selectively cytotoxic to glioma stem cells and effectively cooperates with differentiation therapy to eliminate tumor-initiating cells in glioma … | International Journal of Molecular Sciences | Masashi Okada Shuhei Suzuki Keita Togashi Asuka Sugai Masahiro Yamamoto | 2021/10/27 |
Lurasidone sensitizes cancer cells to osimertinib by inducing autophagy and reduction of survivin | Anticancer Research | Shuhei Suzuki Masahiro Yamamoto Tomomi Sanomachi Keita Togashi Shizuka Seino | 2021/9/1 |
Dexamethasone sensitizes cancer stem cells to gemcitabine and 5-fluorouracil by increasing reactive oxygen species production through nrf2 reduction | Life | Shuhei Suzuki Masahiro Yamamoto Tomomi Sanomachi Keita Togashi Asuka Sugai | 2021/8/27 |
Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties | Genes | Kenta Kuramoto Masahiro Yamamoto Shuhei Suzuki Keita Togashi Tomomi Sanomachi | 2021/1/14 |
Inhibition of the lipid dropletperoxisome proliferator-activated receptor α axis suppresses cancer stem cell properties. Genes. 2021; 12: 99 | K Kuramoto M Yamamoto S Suzuki K Togashi T Sanomachi | 2021 | |
Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1–JNK axis | Journal of Biological Chemistry | Shuhei Suzuki Masashi Okada Tomomi Sanomachi Keita Togashi Shizuka Seino | 2020/12/25 |
Inhibition of retinoblastoma cell growth by CEP1347 through activation of the P53 pathway | Anticancer Research | Keita Togashi Masashi Okada Shuhei Suzuki Tomomi Sanomachi Shizuka Seino | 2020/9/1 |
Doxazosin, a classic alpha 1-adrenoceptor antagonist, overcomes osimertinib resistance in cancer cells via the upregulation of autophagy as drug repurposing | Biomedicines | Shuhei Suzuki Masahiro Yamamoto Tomomi Sanomachi Keita Togashi Asuka Sugai | 2020/8/5 |
Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells | The FEBS Journal | Kenta Kuramoto Masahiro Yamamoto Shuhei Suzuki Tomomi Sanomachi Keita Togashi | 2020/5 |
Co-Authors
